PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

JCI online early table of contents: Nov. 8, 2010

2010-11-09
(Press-News.org) EDITOR'S PICK: PIT(-1)ting good and bad outcomes against each other in breast cancer

The outlook for patients with breast cancer is determined in part by whether or not their tumor has spread to other sites in the body. A team of researchers, led by Roman Perez-Fernandez and colleagues, at the University of Santiago de Compostela, Spain, has now identified in a subset of patients with breast cancer, a marker associated with the occurrence of tumors at distant sites; a finding that they hope might help predict a patient's outlook more accurately. Specifically, the team found that in patients with breast cancer that was accompanied by the presence of tumor cells in nearby lymph nodes, high levels of expression of the protein Pit-1 were associated with tumor spread to distant sites. The authors therefore suggest that analysis of Pit-1 expression in human breast tumor samples could help predict the outlook for patients with lymph node–positive breast cancer.

TITLE: Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis

AUTHOR CONTACT:
Roman Perez-Fernandez
University of Santiago de Compostela, Santiago de Compostela, Spain.
Phone: 34.8818.12257; Fax: 34.981.574145; E-mail: roman.perez.fernandez@usc.es.

View this article at: http://www.jci.org/articles/view/42015?key=b82dbe71403c8d490e53

ONCOLOGY: An Enigma for tumor suppression

One of the most well studied suppressors of tumor formation and development is the protein p53. A team of researchers, led by Dong-Soo Im, at the Korea Research Institute of Bioscience and Biotechnology, South Korea, has now provided new insight into how levels of this protein are regulated in human cell lines. Specifically, the team identified a mechanism by which the protein Enigma promotes p53 degradation. Among the several lines of evidence that this mechanism has a role in tumor development and progression was the observation that Enigma promoted human cancer cell line survival and resistance to chemotherapy by suppressing p53-induced cell death in a mouse xenograft model. The authors therefore suggest that Enigma could be new therapeutic target for selective activation of the tumor suppressor p53.

TITLE: Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice

AUTHOR CONTACT:
Dong-Soo Im
Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.
Phone: 82.42.860.4172; Fax: 82.42.860.4597; E-mail: imdongsu@kribb.re.kr.

View this article at: http://www.jci.org/articles/view/42674?key=efd09435f3d59063fb1c

DERMATOLOGY: Improving wound healing in diabetes

Individuals with diabetes are at increased risk of wounds not healing properly, and this leads to over 72,000 amputations each year. Impaired generation of new blood vessels at the wound site is a key factor behind poor wound healing in these patients. This in turn is in part because cells responsible for making new blood vessel–lining cells (endothelial progenitor cells) are functionally impaired. A team of researchers, led by Alex Chen, at the University of Pittsburgh School of Medicine, Pittsburgh, has now identified a reason why endothelial progenitor cells are defective in diabetic mice.

In the study, endothelial progenitor cells were found to express decreased levels of the protein manganese superoxide dismutase and this reduced their ability to contribute to new blood vessel generation, thereby impairing wound healing. Importantly, gene therapy to replace manganese superoxide dismutase in endothelial progenitor cells from diabetic mice improved their wound healing functionality. The authors therefore suggest that a similar gene therapy approach may be of benefit to patients with diabetes.

TITLE: Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice

AUTHOR CONTACT:
Alex F. Chen
University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Phone: 412.624.6769; Fax: 412.648.7107; E-mail: chena5@upmc.edu.

View this article at: http://www.jci.org/articles/view/36858?key=a299074908118e6d4901

MUSCLE BIOLOGY: A complement to muscle wasting

Individuals with mutations in their dysferlin gene develop one of a group of muscle-wasting diseases sometimes referred to as dysferlinopathies. The exact mechanism(s) underlying the muscle wasting in these individuals is not completely understood. Now, a team of researchers, led by Kevin Campbell, at The University of Iowa, Iowa City, has identified a role for a component of the immune system that is involved in promoting inflammation (specifically, the complement system) in the muscle disease experienced by mice that lack dysferlin and thereby model dysferlinopathies. Among the several lines of evidence generated to support this conclusion was the observation that genetic manipulation of dysferlin-deficient mice such that the lacked the central complement protein C3 ameliorated the muscle wasting observed in dysferlin-deficient mice. These data lead the authors to suggest that targeting the complement system might provide a way to treat dysferlinopathies.

TITLE: Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice

AUTHOR CONTACT:
Kevin P. Campbel
Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
Phone: 319.335.7867; Fax: 319.335.6957; E-mail: Kevin-campbell@uiowa.edu.

View this article at: http://www.jci.org/articles/view/42390?key=1aea8d028bb4436c8ab1

PULMONARY BIOLOGY: Explaining a key aspect of an inherited lung disease

Some individuals inherit a defect in production of the protein alpha-1 antitrypsin (AAT). This causes a chronic lung disease that is characterized by excessive numbers of immune cells known as neutrophils in the lungs. A team of researchers, led by Emer Reeves, at the Royal College of Surgeons in Ireland, has now identified two mechanisms explaining why human neutrophils accumulate in the lungs of individuals with an AAT deficiency, something previously unknown. Of clinical interest, AAT augmentation therapy counteracted these mechanisms, providing insight into why it works to reduce the lung disease associated with AAT deficiency.

TITLE: alpha-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8

AUTHOR CONTACT:
Emer P. Reeves
Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Ireland.
Phone: 353.1.8093877; Fax: 353.1.8093808; Email: emerreeves@rcsi.ie.

View this article at: http://www.jci.org/articles/view/41196?key=aa6adc1ee1b4975f1356

HEMATOLOGY: Rescuing red blood cell production after a bone marrow transplant

Bone marrow transplantation is used to treat some forms of cancer and some other diseases that affect blood cells. One complication after a bone marrow transplant is anemia, i.e., low levels of red blood cells. Robert Paulson and colleagues, at Pennsylvania State University, University Park, have now identified a pathway responsible for the production of new red blood cells shortly after bone marrow transplantation in mice. Specifically, they find that signaling initiated by the protein BMP4 promotes the development of red blood cell precursors in the spleen. These cells act to produce red blood cells in the immediate aftermath of bone marrow transplantation and function until the bone marrow transplant has taken hold and can take over the job of generating red blood cells. The authors point out that it might be possible to promote red blood cell production by targeting the BMP4 signaling pathway but that it will be necessary to determine whether or not this pathway functions in humans before its real clinical impact is known.

TITLE: Murine erythroid short-term radioprotection requires a BMP4-dependent, self-renewing population of stress erythroid progenitors

AUTHOR CONTACT:
Robert F. Paulson
Pennsylvania State University, University Park, Pennsylvania, USA.
Phone: 814.863.6306; Fax: 814.863.6140; E-mail: rfp5@psu.edu.

View this article at: http://www.jci.org/articles/view/41291?key=2756ef91cfa2b2e8f486

###



ELSE PRESS RELEASES FROM THIS DATE:

Research into adolescent sexual habits reveals surprising findings

2010-11-09
Females are more likely to have an unprotected first sexual encounter than their male counterparts. This finding was a surprise to Nicole Weller, an Arizona State University graduate student working toward her doctoral degree in sociology, who presented preliminary findings on research she is conducting on the relationship between early sex education and the onset of sexual activity at the 138th annual American Public Health Association Social Justice Meeting and Expo in Denver on Monday, Nov. 8. Weller is a student in the School of Social and Family Dynamics in the College ...

PPIs and antiplatelet drugs can be used together after careful consideration of risks and benefits

2010-11-09
Using proton pump inhibitors (PPIs) and antiplatelet drugs (thienopyridines) together is an appropriate way of treating patients with cardiovascular (CV) disease who are at high risk of upper gastrointestinal (GI) bleeds, despite recent concerns about an adverse interaction between these two types of drugs, according to an Expert Consensus Document released jointly today by the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG), and the American Heart Association (AHA). The potential benefits of antiplatelet therapy for patients ...

Silent vascular disease accompanies cognitive decline in healthy aging

2010-11-09
(SACRAMENTO, Calif.) — Older people who are leading active, healthy lifestyles often have silent vascular disease that can be seen on brain scans that affect their ability to think, according to a new study led by UC Davis researchers and published online today in the Archives of Neurology, one of the JAMA Archives journals. "This study shows that silent vascular disease is really common as we get older and it influences our thinking abilities," said Charles DeCarli, professor of neurology in the School of Medicine at UC Davis and director of the UC Davis Alzheimer's ...

Although less prevalent, physician-industry relationships remain common

2010-11-09
A new survey finds that, while the number of physicians who report having relationships with pharmaceutical manufacturers or other industrial companies has dropped in recent years, the vast majority of them still maintain such relationships. The study, conducted by the Mongan Institute for Health Policy (IHP) at Massachusetts General Hospital (MGH), appears in the Nov. 8 Archives of Internal Medicine and also documents changes in the frequency of particular types of relationships. "While physician-industry relationships have decreased significantly since 2004, they ...

Alternative treatment for preventing relapse of certain type of vasculitis appears less effective

2010-11-09
In a comparison of treatments for maintaining remission of a certain type of vasculitis (inflammation of blood vessels), the immunosuppressant mycophenolate mofetil, regarded as an alternative to the drug often used to prevent relapse, azathioprine, was less effective, according to a study that will appear in the December 1 print edition of JAMA. The study is being released early online to coincide with its presentation at the American College of Rheumatology annual scientific meeting. "Relapses of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) ...

Survey suggests that many physicians still have relationships with industry

2010-11-09
Relationships with drug manufacturers, device companies and other medical companies appear to be have decreased since 2004 but remain common among physicians, according to a report in the November 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. "The medical profession has embraced the importance of placing patient welfare ahead of financial benefits to physicians in clinical decision making," the authors write as background information in the article. "One tenet of medical professionalism is managing conflicts of interest related to physician-industry ...

Starting dialysis earlier may be harmful for some patients

2010-11-09
Beginning dialysis therapy earlier in the development of advanced kidney disease appears to be associated with a greater risk of death for some patients in the following year, according to a report posted online today that will be published in the March 14 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Dialysis—a procedure in which a machine performs the blood-filtering functions of the kidneys—should help patients with advanced kidney disease live longer, reduce their illness burden and improve their quality of life, according to background ...

Clinical research doesn't do enough to study sex and gender differences

2010-11-09
Potential gender differences in clinical management are under-researched. A systematic analysis of the incorporation of sex and gender into research design, published in the open access journal BMC Medicine, has found that, although there has been a progressive improvement since the 90s, there exists a striking under-representation of research about gender differences in patient management. Sabine Oertelt-Prigione, from the Institute of Gender in Medicine, Berlin, worked with a team of researchers to study almost 9000 research articles, looking for evidence of sex and ...

Many patients having heart attacks still wait more than 2 hours to go to the hospital

2010-11-09
Long delays between developing symptoms and going to the hospital are common among patients with a certain type of heart attack, according to a report in the November 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Professional guidelines recommend that patients call 9-1-1 if symptoms suggestive of a heart attack do not improve within five minutes, according to background information in the article. Medical treatment is most urgent in patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram ...

'Sweet 16' tool may be useful for detecting cognitive impairment

2010-11-09
A new cognitive assessment tool with 16 items appears potentially useful for identifying problems in thinking, learning and memory among older adults, according to a report posted online today that will be published in the March 14 print issue of Archives of Internal Medicine, one of the JAMA/Archives journals. An estimated 3.4 million older adults in the United States have dementia, and an additional 5.4 million have milder forms of cognitive impairment, according to background information in the article. "For many older adults, cognitive impairment contributes to loss ...

LAST 30 PRESS RELEASES:

Study identifies candidates for therapeutic targets in pediatric germ cell tumors

Media alert: The global burden of CVD

Study illuminates contributing factors to blood vessel leakage

What nations around the world can learn from Ukraine

Mixing tree species does not always make forests more drought-resilient

Public confidence in U.S. health agencies slides, fueled by declines among Democrats

“Quantum squeezing” a nanoscale particle for the first time

El Niño spurs extreme daily rain events despite drier monsoons in India

Two studies explore the genomic diversity of deadly mosquito vectors

Zebra finches categorize their vocal calls by meaning

Analysis challenges conventional wisdom about partisan support for US science funding

New model can accurately predict a forest’s future

‘Like talking on the telephone’: Quantum computing engineers get atoms chatting long distance

Genomic evolution of major malaria-transmitting mosquito species uncovered

Overcoming the barriers of hydrogen storage with a low-temperature hydrogen battery

Tuberculosis vulnerability of people with HIV: a viral protein implicated

Partnership with Kenya's Turkana community helps scientists discover genes involved in adaptation to desert living

Decoding the selfish gene, from evolutionary cheaters to disease control

Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

[Press-News.org] JCI online early table of contents: Nov. 8, 2010